Cargando…
Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapy
BACKGROUND AIMS: Mesenchymal stromal cells (MSCs) are being extensively researched for cell therapy and tissue engineering. We have engineered MSCs to express the pro-apoptotic protein tumor necrosis factor–related apoptosis inducing ligand (TRAIL) and are currently preparing this genetically modifi...
Autores principales: | Yuan, Zhengqiang, Lourenco, Sofia Da Silva, Sage, Elizabeth K., Kolluri, Krishna K., Lowdell, Mark W., Janes, Sam M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906234/ https://www.ncbi.nlm.nih.gov/pubmed/27260207 http://dx.doi.org/10.1016/j.jcyt.2016.04.005 |
Ejemplares similares
-
Mesenchymal stromal cell delivery of full-length tumor necrosis factor–related apoptosis-inducing ligand is superior to soluble type for cancer therapy
por: Yuan, ZhengQiang, et al.
Publicado: (2015) -
Systemic but not topical TRAIL-expressing mesenchymal stem cells reduce tumour growth in malignant mesothelioma
por: Sage, Elizabeth K, et al.
Publicado: (2014) -
TRAIL delivery by MSC-derived extracellular vesicles is an effective anticancer therapy
por: Yuan, ZhengQiang, et al.
Publicado: (2017) -
Lung delivery of MSCs expressing anti-cancer protein TRAIL visualised with (89)Zr-oxine PET-CT
por: Patrick, P. Stephen, et al.
Publicado: (2020) -
Genetically modified mesenchymal stromal cells in cancer therapy
por: Sage, Elizabeth K., et al.
Publicado: (2016)